Infliximab

infliximab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

150 regulatory and trial events tracked for Infliximab, covering 2006-05-19 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE） [Phase 4]